Khiron Life Sciences Corp. (TSXV:KHRN) was featured in a speculative buy report by Canaccord Genuity, an independent full-service financial services firm. The basis for the report was based on Khiron’s first mover advantage and the emerging legalized cannabis markets in Latin America.

Khiron operates out of Colombia, which offers optimal growing conditions, cost advantages, liberal prescribing regulations and a medical cannabis market comprised of approximately 700,000 patients. The report concluded, that the Latin American cannabis market has a potential to make $8 to $9 billion annually. The report highlighted Khiron’s facilities in Colombia, which will be able to produce approximately 16,900 kilograms of cannabis per year and will be able to service approximately 100,000 patients. The company is expecting its first harvest in late 2018 and expects sales to commence in early 2019.


The report also touched on Khiron’s established medical cannabis patient network of approximately 400,000 patients. Their patient base has been developed through their education platform and their strategic alliances with 3,000 doctors. The company is also in the process of closing an acquisition for the ILANS clinics, which could bring an additional 100,000 patients to its portfolio. The first clinic is expected to be operational by the end of 2018 depending on the closing of the acquisition.

These two factors, among others, provided the basis for the report’s $3 speculative buy rating.

 

Click here to connect with Khiron Life Sciences Corp. (TSXV:KHRN) for an Investor Presentation.

Source: canaccordgenuity.bluematrix.com

Trulieve Cannabis Corp. (“Trulieve” or the “Company”) (CSE: TRUL) (OTCQX: TCNNF), a leading and top-performing cannabis company in the United States today announced the appointment of Marcum LLP (“Marcum”) as its independent registered public accounting firm, effective July 5, 2021 . Marcum was appointed following the resignation of MNP LLP (“MNP”) as the Company’s independent registered public accounting firm effective July 5, 2021 .

“We would like to thank MNP for their guidance and expertise over the past two years and we look forward to working with Marcum as the Company’s new independent registered public accounting firm,” stated Chief Financial Officer, Alex D’Amico.

Keep reading... Show less

Cannabis-infused beverages are not a new product concept, but this summer Canadian drink makers hope consumers will discover them for the first time.

Recreational cannabis beverages have beguiled Canadian producers through different avenues, and many continue to make investments. The promise of these drinks lies in the potential of a more welcoming option for new consumers who may be out of their depth with rolled-up dried flower.

Keep reading... Show less

In the news release, BioHarvest Sciences Inc.‘s First Cannabis Cell Reservoir Produces Ongoing Flowering Stage Cannabinoid Cells For 2 Years, issued 07-Jul-2021 by BioHarvest Sciences Inc. over PR Newswire, we are advised by the company that an incorrect version of the release was issued inadvertently. The complete, corrected release follows:

BioHarvest Sciences Inc.‘s First Cannabis Cell Reservoir Produces Ongoing Flowering Stage Cannabinoid Cells For 2 Years

Keep reading... Show less

Trulieve is the first medical cannabis operator to start planting in the state

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today that it commenced operations in West Virginia . The Company has begun cultivation at their 100,000 square foot size facility in Huntington, West Virginia .

Keep reading... Show less

– The Company demonstrates the efficiency and reliability of its BioFarming technology by reducing production cycle time for Cannabis from 14-23 weeks to 3-4 weeks.

– The Company’s BioFarming technology will allow the Company to harvest 13-17 cycles per year versus 2-4 cycles per year for conventional Cannabis agriculture.

Keep reading... Show less